85-4054-35 Ruxolitinib, Free Base 10mg CAS No:941678-49-5 288929
特徴
- Ruxolitinib is a potent and selective Janus kinase (JAK) inhibitor with with IC50's of 2.7 and 4.5nm for JAK1 and JAK2, respectively. Displays clinically significant activity in myelofibrosis.
- Melting Point:137-145ºC
- Solubility:Souble in DMSO at 28mg/ml. Soluble in ethanol at 15mg/ml with warming; very poorly soluble in water; maximum solubility in plain water is estimated to be about 25-50uM; buffers, serum or other additives may increase or decrease the aqueous solubility
- Elemental Analysis:Calculated:%C: 66.65%H: 5.92%N: 27.43%
- Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 6 months after receipt at -20°C. Reconstitute with DMSO or EtOH. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Light sensitive.
仕様
- Size:10mg
- Grade:Purified
- Purity:≥99% (HPLC, TLC)
- Form:Supplied as a white to off-white powder
- Molecular Formula:C17H18N6
- Molecular Weight Non Ab:306.37
- EU Commodity Code:38220090
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- CAS No :941678-49-5
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
85-4054-35
Ruxolitinib, Free Base 10mg
|
|
|
85-4054-34
Ruxolitinib, Free Base 5mg
|
|
|
85-4054-38
Ruxolitinib, Free Base 100mg
|
|
|
85-4054-37
Ruxolitinib, Free Base 50mg
|
|
|
85-4054-36
Ruxolitinib, Free Base 25mg
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





